Ambey Laboratories Past Earnings Performance
Past criteria checks 3/6
Ambey Laboratories has been growing earnings at an average annual rate of 27.8%, while the Chemicals industry saw earnings growing at 16.3% annually. Revenues have been growing at an average rate of 26.5% per year. Ambey Laboratories's return on equity is 19.3%, and it has net margins of 4.3%.
Key information
27.8%
Earnings growth rate
-63.7%
EPS growth rate
| Chemicals Industry Growth | 17.7% |
| Revenue growth rate | 26.5% |
| Return on equity | 19.3% |
| Net Margin | 4.3% |
| Last Earnings Update | 31 Mar 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Ambey Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 1,074 | 46 | 36 | 0 |
| 31 Mar 22 | 849 | 36 | 30 | 0 |
| 31 Mar 21 | 821 | 103 | 28 | 0 |
| 31 Mar 20 | 670 | 2 | 52 | 0 |
Quality Earnings: AMBEY has high quality earnings.
Growing Profit Margin: AMBEY's current net profit margins (4.3%) are higher than last year (4.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if AMBEY's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare AMBEY's past year earnings growth to its 5-year average.
Earnings vs Industry: AMBEY earnings growth over the past year (27.8%) exceeded the Chemicals industry 2.4%.
Return on Equity
High ROE: AMBEY's Return on Equity (19.3%) is considered low.